INmune Bio is pairing a quantum machine with AI to find diseases beyond Alzheimer’s that its drug candidate might help.
Immorta Bio says its AI-designed SenoMune-0257 prompts T cells to clear senescent cells, and plans first human evaluation ...
TimePie's Hebe Chen spotlights key developments from Shanghai, from therapeutic targets to China’s expanding clinical ...
A new review argues postpartum recovery may shape lifelong aging; a fandom health standard asks who helps mothers get there.
Zealand Pharma’s petrelintide delivered up to 9.2% weight loss over 28 weeks in people with obesity and type 2 diabetes, with few dropouts. Here is the figure that jumped out first. Just 1.9% of ...
Niagen Bioscience’s new Niagen Plus vial comes pre-filled and needs no mixing. It is available via a telehealth platform from ...
Cognition Therapeutics wins a US patent on a new crystal form of zervimesine and has an FDA meeting on its Lewy body trial ...
Zealand Pharma and Generate Biomedicines will design multispecific proteins for metabolic disease, in a deal with nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results